Published by Josh White on 9th March 2021
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics said on Tuesday that Australia's Therapeutics Goods Administration (TGA) has registered 'Feraccru' in the country's Register of Therapeutic Goods, to treat iron deficiency with or without anaemia in adults.
URL: http://www.digitallook.com/dl/news/story/31696607/...